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Department of Pathology, Molecular Pathology Unit, Faculty of Medicine, P.O. Box 24923, Safat, Kuwait 13110, KuwaitSubstantial efforts are beingmade at cataloging the genetic variation
in various populations, because a better knowledge of the normal genet-
ic variation, which is often population-speciﬁc, will become essential to
interpret genetic variation in patients with speciﬁc diseases. The Dutch
government, for example, has funded the “Genome of the Netherland
(GoNL)” (http://www.nlgenome.nl/; Francioli et al., 2014) initiative
where whole genomes from more than 750 subjects, mainly trios of
two parents and one adult child, were sequenced. A similar endeavor
is starting in Belgium, and in other European countries, under the
aegis of the European Biobanking and Biomolecular Resources Research
Infrastructure (BBMRI) (http://bbmri-eric.eu/).
Scientists in the West and Far-East realized early on, before the
emergence of next generation sequencing, that classifying even a single
variant in a speciﬁc gene presents formidable challenges. What does a
“p.M167R” variant in a particular genemean for the patient if we cannot
compare it to other patients affected by the same disease or unaffected
controls? To meet this need, scientists in developed countries have
established, and are still establishing, disease/locus-speciﬁc databases
that contain information detailing variations in genes predisposing to
speciﬁc diseases. Luckily, most have open access policies for registered
academics, so that one can easily compare the variants identiﬁed in
their patients to those populating the databases and make a clinical
decision based on the ﬁndings (Fokkema et al., 2011).
Currently, single gene-based variations are classiﬁed into catego-
ries like pathogenic, non-pathogenic, likely pathogenic, likely non-
pathogenic or pathogenicity uncertain, augmented by additional genetic
information from other family members, other research ﬁndings of the
variant independently in patients with similar presentation, and results
of functional experiments to directly document causality (Thomson
et al.). Difﬁculties in accurately interpreting genomic variation data
that complicate classiﬁcation were recently highlighted in a review pub-
lished in this journal (http://www.sciencedirect.com/science/article/pii/
S2212066114000155). The fact that most disease-speciﬁc databases
are population speciﬁc renders them less useful for a researcher based
in the Middle East. Moreover, clinical knowledge is constrained by the
need to surf large numbers of separate LSDBs for a similar variant depos-
ited somewhere. This is especially true formany variants in a single gene.
In 2004, the Center for Arab Genomic Studies, which is based in the
United Arab Emirates (http://www.cags.org.ae/index.html), initiated a
project that attempts to construct a catalog of genetic mutations in
Arabs. The effort, listed 1580 Mendelian disorders and related genesTel.: +965 67771040; fax: +965 25338905.
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(Tadmouri et al., 2006). This literature based effort, although commend-
able, suffers from signiﬁcant limitations exempliﬁed by its dependence
on published and non-curated entries as well as our inability to populate
it with rich unpublished data. For researchers and clinicians alike this
adds further difﬁculties because they must search yet another database
to identify the clinical signiﬁcance of a variant in question.
To alleviate this we recommend a universal gene- or disease-based
LSDB, which contains gene-variation data from around the world. A
formidable example of such an effort is highlighted by the InSIGHT-
group database (InSIGHT.org), which contains collected, curated and
classiﬁed variations in 11 genes associated with hereditary colorectal
cancer (HNPCC). There is no such database for Arab patients with
HNPCC and we, therefore, opted not to build a new LSDB for hereditary
polyposis coli (HNPCC) in Arab subjects and instead submitted our
Kuwaiti HNPCC data to the InSIGHT database (http://insight-
group.org/). If other researchers contribute to the InSIGHT, then a
truly international database will have been established, which can
beneﬁt all researchers wherever they are situated around the world.
Despite the strength of LSDBs, classiﬁcation challenges will likely be
magniﬁed when whole genomes (3-billion nucleotides) or exomes (all
25,000 gene or so) are examined. In light of the absence of an Arab pop-
ulationwide database to be populated, decisions aboutwherewe depos-
it our growing amount of variant data are important not only for
optimizing research and clinical utility but for ensuring open access
and data sharing.
Admittedly, Arab scientists began examining whole genome se-
quences using next generation sequencing (NGS) quite late. Howev-
er,we realized early on the need to establish an Arab population speciﬁc
NGS database, a move similar to the 1000 human genome project, to at
least construct a platform through which additional raw sequences can
be aligned and compared. Our goal faces major challenges, particularly
as a less resourced country. Although Kuwait and the Gulf states are
oil-rich countries, in reality only as much as 0.1–2.5% of Gross National
Product (GDP) is allocated for Research and Development (Giles, 2006).
Funding is therefore, a major challenge to advancing translational geno-
mic research. Open databases are therefore crucial to our research
progress. Thus, for us the impact of decisions to open or close genome
databases is great.
In Kuwait, we have sequenced a limited number of whole genomes
and exomes from which we estimate at least 600–700 novel genetic
variations have been identiﬁed and classiﬁed as damaging (they are
expected to alter the protein structure and function) in each apparently
normal individual. Fig. 1 shows a summary of genetic variants obtainedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Exome sequencing summary obtained from 8 Arab control subjects including a trio family (cases 6–8).
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70×. Our ambition to build on these efforts and establish an Arab popula-
tion database is constrained, however, by the limited understanding of
the importance of genetics research and the unjustiﬁed fear from
policymakers, citizens and even clinicians inArab countries about dissem-
inating genetic sequences, which hampers our ability to gain enough
funding (http://www.the-scientist.com/?articles.view/articleNo/
30725/title/Another-Revolution-Needed-/; http://blogs.nature.com/
tradesecrets/author/Fahd-Al-Mulla).
Luckily, Qatar National Research Fund funded part of our venture.
However, independently, they are pursuing thewhole genome sequenc-
ing of 300,000 Qatari nationals (http://www.gulf-times.com/qatar/178/
details/374345/qatar-launches-genome-project). The Saudis have also
initiated the sequencing of about 100,000 Arabs from around the
Kingdom (http://rc.kfshrc.edu.sa/sgp/). It appears likely that data gener-
ated from both ambitious projects will be unconnected because science
in a number of Arab countries is not viewed as a necessity but rather is
politically driven with a focus on national merit. Genome sequencing,
thus, is viewed only as a national endeavor rather than a humanitarian
triumph or necessity. It is vital that policymakers understand that
regional genome sequences have little translational inﬂuences if not
compared and contrasted to other populations worldwide.
We coined the term “Locked genomes” to describe unshared NGS
data. In January 2014, under the umbrella of the National Institutes of
Health (NIH), key global leaders in genomicmedicine convened todiscuss
ways of accelerating the implementation of genomics in medical practice
worldwide. In the meeting, we realized that most international partici-
pants, as expected, useNGS to obtain limited variant data to aid in speciﬁc
diagnosis and the rest of the potentially valuable data is discarded
or stored locally. In other words, the genome sequences are locked. This
is unfortunate given that the most important lesson we have learned
from the human genome project and LSDBs is that sequence variants
need to be compared to be clinically useful.
Arguably, the process of accumulating, sharing and comparing geno-
mic sequences is the best, if not the only, way at our disposal to facilitate
our understanding of genotype–phenotype relationship. Locking ge-
nomes, as we see it, contradicts the goal of genomic research, namely
that the beneﬁts be shared globally. The Exome Variant Server project
(NHLBI Exome Sequencing Project), a pioneer effort to discover novelgenes and mechanisms contributing to heart, lung and blood disorders,
which is a collection of exome sequences and some of the largest well
phenotyped population databases in the US, highlights this point very
well because it brings to our disposal allele frequencies of variants from
the Caucasian and African American populations. This information is im-
portant for clinicians to know at a glance whether a variant could have
pathogenic potential (rare) or is a neutral polymorphism (common).
Of course it will be ideal to have a similar but more elaborate data-
base dedicated for international researchers involved in NGS in which
to deposit their sequencing data. Such an effort should contain essential
but not necessarily exhaustive phenotype data and it will ensure that
the beneﬁts of genomic research are not only available to the wealthy,
provided ethical guidelines are duly applied. This possible roadmap
may alleviate the clinicians' suffering and unlock the genomes' wealth
beyond our wildest dreams. We are at an important cusp. Genomes
must be open, particularly for researchers in the less resourced coun-
tries, if research is to progress and beneﬁts actualized. Future policy
initiatives at the global and national level must support this goal.
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